Forbes Simvastatin and pravastatin were better tolerated than other statins while atorvastatin and rosuvastatin were associated with more discontinuations. People taki...
MedPage Today The study initially included trials of atorvastatin, fluvastatin, simvastatin, lovastatin, pravastatin, and rosuvastatin (Crestor); trials of pitavastatin (Livalo) were added post hoc because the protocol was already being finalized at the time the ...
StreetInsider.com (subscription) Amarin Corporation plc (Nasdaq: AMRN) announced the results from a Phase 1 clinical trial that compared bioavailability of components fr...
Medscape SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. ClinPharmacolTher. 2006;80:356–66. Cuisset T, Morange PE, Alessi MC. Recent advances in the pharmacogenetics of clopidogrel. Hum Genet. 2012;131:653–64.
StreetInsider.com (subscription) Amarin Corporation plc (Nasdaq: AMRN) announced the results from a Phase 1 clinical trial that compared bioavailability of components fr...
MarketWatch On June 21, 2013, Amarin Corporation plc (Amarin) announced positive results from the Phase I clinical trial that compared the bioavailability of components from a fixed-dose combination of Vascepa (icosapent ethyl) and rosuvastatin (AMR-102), ...
StreetInsider.com (subscription) Amarin Corporation plc (Nasdaq: AMRN) announced the results from a Phase 1 clinical trial that compared bioavailability of components fr...
Renal and Urology News In a retrospective study of individuals aged 66 years and older, the researchers found a 22% increased risk of incident diabetes associated with atorvastatin use, an 18% increased risk with rosuvastatin use, and a 10% increased risk with simvastatin ...
The Star Online There are few drugs in the history of medicine that have saved as many lives and prevented so many heart attacks in its short life span of 25 years as the “statins”, a class of drugs including lovastatin, simvastatin, atorvastatin and rosuvastatin ... and more »
Toronto NewsFIX They were given either a combination of ezetimibe and rosuvastatin or rosuvastatin on its own. Those on the combination therapy had a bigger reduction in C-reactive protein (CRP) than did those on monotherapy. CRP is a known marker for inflammation, ... and more »
